AccelBio is a pharmaceutical contract research organization (CRO) and diagnostic testing development and point-of-care services company. We provide actionable results for biotechnology programs and pharmaceutical research and discovery with a focus on customized RNA and neurobiology research. With our expertise in molecular cell biology and animal work, we leverage premier bioassays in multiple formats, including high-throughput screens using chemically unique entities for drug discovery. Currently we are applying our RNA expertise to develop novel, rapid high-throughput Viral RNA diagnostic platforms for COVID-19 detection globally. Our contract services enable the highest quality R&D focused on genetic models and disease pathways. White-glove COVID-19 and other pathogen screening services.
Company Details
- Employees
- 4
- Address
- 760 Parkside Avenue, Brooklyn,new York 11226,united States
- Industry
- Biotechnology
- Website
- accelbio.com
- HQ
- Brooklyn, New York
Accelbio Questions
Accelbio's website is accelbio.com
Accelbio's LinkedIn profile is https://www.linkedin.com/company/accelbio
Accelbio has
4 employees.
View email and phone details for 4
employees at Accelbio.
Accelbio's industry is
Biotechnology
Accelbio's top competitors are
Evergreen Biosciences®,
Microharvest,
Colab Accelbio,
Entogreen,
Silicolife,
Nzytech,
P-Bio - Associação Portuguesa De Bioindústria,
Bristol Myers Squibb,
Ventilaqua,
Fortress Biotech.
Accelbio's categories are Biotechnology
